🍂 Enjoy the Fall Season! 🍂
MindTheDesk

AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies

Gillette Archived • August 27, 2026 • 2 views
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate AHB-171 and next-generation combination approaches designed to advance functional cure for chronic hepatitis BSeries C brings AusperBio's total capital raised…
Source: Gillette News Record | https://www.gillettenewsrecord.com/search/?f=rss&t=article&l=50&s=start_time&sd=desc - Read Original
"We build AI or anything ICST"
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Free Quote Today"
"Retirement Health Care"